Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma

Blood

Volumn 102, Issue 12, 2003, Pages 4166-4178

  Portis, Toni ^a   Dyck, Patricia ^a   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; LATENT MEMBRANE PROTEIN 1; LATENT MEMBRANE PROTEIN 2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL MATURATION; DNA METABOLISM; EPSTEIN BARR VIRUS; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; RNA METABOLISM; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0345257290     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-04-1018     Document Type: Article

References (53)

1. Keiff E, Rickinson A. Epstein-Barr virus and its replication. In: Knipe D, Howley P, eds. Fields Virology. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2001:2511-2573.
2. Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nature Rev Immunol. 2001;1:75-82.
3. Chen F, Zou JZ, di Renzo L. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol. 1995;69:3752-3758.
4. Chen H, Smith P, Ambinder RF, Hayward SD. Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. Blood. 1999;93:3026-3032.
5. Qu L, Rowe D. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol. 1992;66:3715-3724.
6. Tierney RJ, Steven N, Young LS, Rickinson AB. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol. 1994;68:7374-7385.
7. Kuppers R, Schwering I, Brauninger A, Rajewsky K, Hansmann M-L. Biology of Hodgkin's lymphoma. Ann Oncology. 2002;13:11-18.
8. Cossman J, Annunziata CM, Barash S, et al. Reed-Sternberg cell genome expression supports a B-cell lineage. Blood. 1999;94:411-416.
9. Marafioti T, Hummel M, Foss H-D, et al. Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood. 2000;95:1443-1450.
10. Khan G, Coates PJ. The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease. J Pathol. 1994;174:141-149.
11. Pallesen G, Hamiiton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet. 1991;337:320-322.
12. Wu TC, Mann RB, Charache P, et al. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer. 1990;46:801-804.
13. Dykstra ML, Longnecker R, Pierce SK. Epstein-Barr virus coopts lipid rafts to block the signaling and antigen transport functions of the BCR. Immunity. 2001;14:57-67.
14. Longnecker R. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Adv Cancer Res. 2000;79:175-200.
15. Miller CL, Longnecker R, Kef E. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J Virol. 1993;67:3087-3094.
16. Miller CL, Burkhardt AL, Lee JH, et al. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity. 1995;2:155-166.
17. Burkhardt AL, Bolen JB, Kef E, Longnecker R. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J Virol. 1992;66:5161-5167.
18. Fruehling S, Longnecker R. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology. 1997;235:241-251.
19. Fruehling S, Swart R, Dolwick KM, Kremmer E, Longnecker R. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency. J Virol. 1998;72:7796-7806.
20. Caldwell RG, Wilson JB, Anderson SJ, Longnecker R. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity. 1998;9:405-411.
21. Caldwell RG, Brown RC, Longnecker R. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EuLMP2A transgenic mice. J Virol. 2000;74:1101-1113.
22. Merchant M, Caldwell RG, Longnecker R. The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J Virol. 2000;74:9115-9124.
23. Engels N, Merchant M, Pappu R, Chan AC, Longnecker R, Wienands J. Epstein-Barr virus latent membrane protein 2a (LMP2A) employs the SLP-65 signaling module. J Exp Med. 2001;194:255-264.
24. Merchant M, Longnecker R. LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways. Virology. 2001;291:46-54.
25. Portis T, Longnecker R. Epstein-Barr virus (EBV) LMP2A interferes with global transcription factor regulation when expressed during B lymphocyte development. J Virol. 2003;77:105-114.
26. Ikeda M, Ikeda A, Longan LC, Longnecker R. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases. Virology. 2000;268:178-191.
27. Miller CL, Lee JH, Kef E, Longnecker R. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci U S A. 1994;91:772-776.
28. Ikeda M, Ikeda A, Longnecker R. PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins. J Virol. 2001;75:5711-5718.
29. Longnecker R, Merchant M, Brown ME, et al. WW- and SH3-domain interactions with Epstein-Barr virus LMP2A. Exp Cell Res. 2000;257:332-340.
30. Hertel CB, Zhou X, Hamilton-Dutoit SJ, Junker S. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma. Oncogene. 2002;21:4908-4920.
31. Hsu P-L, Xie S-S, Hsu S-M. Absence of T-cell- and B-cell-specific transcription factors TCF-1, GATA-3, and BSAP in Hodgkin's Reed-Sternberg cells. Lab Invest. 1996;74:395-405.
32. Jundt F, Kley K, Anagnostopoulos I, et al. Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease. Blood. 2002;99:3060-3062.
33. Schwering I, Brauninger A, Klein U, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2003;101:1505-1512.
34. Kuppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest. 2003;111:529-537.
35. Meru N, Jung A, Lisner R, Niedobitek G. Expression of the recombination activating genes (RAG1 and RAG2) is not detectable in Epstein-Barr virus-associated human lymphomas. Int J Cancer. 2001;92:75-78.
36. Kanavaros P, Stefanaki K, Vlachonikolis J, et al. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's Lymphomas. Histol Histopathol. 2000;15:445-453.
37. Garcia JF, Camacho FI, Morente M, et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood. 2003;101:681-689.
38. Smolewski P, Niewiadomska H, Blonski JZ, Robak T, Krykowski E. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease. Neoplasma. 1998;45:140-147.
39. Samoszuk M, Nansen L. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood. 1990;75:13-16.
40. Skinnider BF, Ella AJ, Gascoyne RD, et al. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2001;97:250-255.
41. Niedobitek G, Pazolt D, Teichmann M, Devergne O. Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J Pathol. 2002;198:310-316.
42. Oshima Y, Puri RK. Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist. Cell Immunol. 2001;211:37-42.
43. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99:4283-4297.
44. Devergne O, Hummel M, Koeppen H, et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol. 1996;70:1143-1153.
45. Klein U, Tu Y, Stolovitzky GA, et al. Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci USA. 2003;100:2639-2644.
46. Rooney CM, Bollard C, Huls MH, et al. Immunotherapy for Hodgkin's disease. Ann Hematol. 2002;81:S39-S42.
47. Jarrett RF. Viruses and Hodgkin's lymphoma. Ann Oncol. 2002;13:S23-S29.
48. Li J, Peet GW, Baizarano D, et al. Novel NEMO/IkB kinase and NF-kB target genes at the pre-B to immature B cell transition. J Biol Chem. 2001;276:18579-18590.
49. Li Z-W, Omori SA, Labuda T, Karin M, Rickert RC. IKKβ is required for peripheral B cell survival and proliferation. J Immunol. 2003;170:4630-4637.
50. Bargou RC, Emmerich F, Krappmann D, et al. Constitutive nuclear factor-kB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest. 1997;100:2961-2969.
51. Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dorken B, Scheidereit C. Molecular mechanisms of constitutive NF-kB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene. 1999;18:943-953.
52. Muljo SA, Schlissel MS. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nature Immunol. 2003;4:31-37.
53. Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H, Dorken B. Activated Notch 1 signaling promotes tumor cell proliferation and survival in Hodgkin's and anaplastic large cell lymphoma. Blood. 2002;99:3398-3403.